Innate and SARS-CoV-2 specific adaptive immune response kinetic in neutralizing monoclonal antibody successfully treated COVID-19 patients.
Casetti R, Sacchi A, Mazzotta V, Cristofanelli F, Grassi G, Gili S, Cimini E, Notari S, Bordoni V, Mastrorosa I, Giancola ML, Vergori A, Tempestilli M, Vita S, Mariotti D, Rosati S, Lalle E, Meschi S, Colavita F, Garbuglia AR, Girardi E, Nicastri E, Antinori A, Agrati C.
Casetti R, et al. Among authors: sacchi a.
Int Immunopharmacol. 2025 Jan 19;148:113934. doi: 10.1016/j.intimp.2024.113934. Online ahead of print.
Int Immunopharmacol. 2025.
PMID: 39832460